J Biol Chem, Vol. 274, Issue 40, 28240-28245, October 1, 1999
Functional Linkage between the Glutaminase and Synthetase Domains
of Carbamoyl-phosphate Synthetase
ROLE OF SERINE 44 IN CARBAMOYL-PHOSPHATE SYNTHETASE-ASPARTATE
CARBAMOYLTRANSFERASE-DIHYDROOROTASE (CAD) *
Anura
Hewagama,
Hedeel I.
Guy,
John F.
Vickrey, and
David R.
Evans
From the Department of Biochemistry and Molecular Biology, Wayne
State University School of Medicine, Detroit, Michigan 48201
 |
ABSTRACT |
Mammalian carbamoyl-phosphate synthetase is part
of carbamoyl-phosphate synthetase-aspartate
carbamoyltransferase-dihydroorotase (CAD), a multifunctional protein
that also catalyzes the second and third steps of pyrimidine
biosynthesis. Carbamoyl phosphate synthesis requires the concerted
action of the glutaminase (GLN) and carbamoyl-phosphate synthetase
domains of CAD. There is a functional linkage between these domains
such that glutamine hydrolysis on the GLN domain does not occur at a
significant rate unless ATP and
HCO3
, the other substrates
needed for carbamoyl phosphate synthesis, bind to the synthetase
domain. The GLN domain consists of catalytic and attenuation
subdomains. In the separately cloned GLN domain, the catalytic
subdomain is down-regulated by interactions with the attenuation
domain, a process thought to be part of the functional linkage.
Replacement of Ser44 in the GLN attenuation domain with
alanine increases the
kcat/Km for glutamine
hydrolysis 680-fold. The formation of a functional hybrid between the
mammalian Ser44 GLN domain and the Escherichia
coli carbamoyl-phosphate synthetase large subunit had little
effect on glutamine hydrolysis. In contrast, ATP and
HCO3
did not stimulate the glutaminase
activity, indicating that the interdomain linkage had been disrupted.
In accord with this interpretation, the rate of glutamine hydrolysis
and carbamoyl phosphate synthesis were no longer coordinated.
Approximately 3 times more glutamine was hydrolyzed by the
Ser44
Ala mutant than that needed for carbamoyl
phosphate synthesis. Ser44, the only attenuation subdomain
residue that extends into the GLN active site, appears to be an
integral component of the regulatory circuit that phases
glutamine hydrolysis and carbamoyl phosphate synthesis.
 |
INTRODUCTION |
In mammals and most other species, the synthesis of carbamoyl
phosphate in the de novo pyrimidine biosynthetic pathway
occurs in a series of four partial reactions (1, 2) that are catalyzed by distinct structural domains of carbamoyl-phosphate synthetase (CPSase,1 EC 6.3.5.5).
Mammalian carbamoyl-phosphate synthetase is part of a large
multifunctional protein called CAD (3-5), which also has aspartate transcarbamoylase and dihydroorotase activities, enzymes that catalyze
the second and third steps of the de novo pathway,
respectively. The 243-kDa CAD polypeptide is organized into discrete
structural domains each with a specific function (6-9). The 38-kDa
glutaminase (GLN) domain located on the amino end of the polypeptide
(10, 11) catalyzes the hydrolysis of glutamine and transfers the ammonia to the adjacent 120-kDa synthetase (CPS) domain, where the
remaining partial reactions take place. The CPS domain of CAD (10) and
all known CPSases (12, 13) consist of two homologous subdomains, CPS.A
and CPS.B (10), that probably arose as a result of an ancestral gene
duplication and fusion (12). Escherichia coli CPSase is a
monofunctional protein (14, 15) consisting of a 42-kDa GLN subunit and
a 120-kDa CPS subunit. Despite differences in structural organization,
the sequence and domain structure of the mammalian and bacterial
proteins are very similar. There is extensive evidence that the two
different ATP-dependent partial reactions, the activation
of bicarbonate (Reaction 2) and the phosphorylation of carbamate
(Reaction 4), are catalyzed by CPS.A and CPS.B, respectively
(16-22).
The x-ray structure of the E. coli enzyme (23-26) has been
solved to a resolution of 1.8 Å. Remarkably, the active sites were found to be widely separated but connected by a narrow tunnel that
passes through the interior of the molecule. The ammonia generated by
hydrolysis of glutamine presumably diffuses through the tunnel to the
active site of CPS.A, where it reacts with carboxy phosphate to form
carbamate. The carbamate then diffuses through the tunnel to the active
site of CPS.B, where carbamoyl phosphate is formed in the second
ATP-dependent reaction.
The mechanism of glutamine hydrolysis by CPSase (27-31) and other
trpG-type amidotransferases (32-34) is analogous to that of the thiol
proteases. The reaction proceeds through a thioester intermediate, and
there is evidence that a catalytic triad consisting of
Cys252, His336, and Glu338 in CAD
promotes catalysis. The thioester was directly observed in the x-ray
structure (24) of an E. coli CPSase mutant. The residues of
the catalytic triad have the expected juxtaposition relative to the
bound intermediate and in addition, Ser47
(Ser44 in CAD) was found to be close to the carbonyl carbon
of the thioester carboxamide group. The authors suggested that this
serine residue may participate in catalysis by positioning the carbonyl
group for nucleophilic attack by the active site cysteine and by
stabilizing the developing oxyanion in the transition state.
The partial reactions are coordinated by a reciprocal linkage between
glutamine hydrolysis and carbamoyl phosphate synthesis. While the GLN
and CPS domains of both E. coli and mammalian CPSase can
function autonomously, many studies (1, 27-31, 35-38) have demonstrated a functional linkage between the active sites that modulates their activities. Glutamine hydrolysis does not proceed at a
significant rate in the absence of ATP and bicarbonate. This functional
linkage minimizes the hydrolysis of glutamine when the other substrates
needed for carbamoyl phosphate synthesis are limiting.
We have previously cloned and expressed the mammalian GLN domain (39)
and showed that the purified recombinant protein forms a stable,
stoichiometric complex with the E. coli CPS subunit. The
hybrid molecule has kinetic parameters that are similar to those of the
GLN domain of intact CAD, and the linkage between the GLN and CPS
domains is fully functional (31, 39). We have used this hybrid molecule
to examine the role of Ser44 and conclude that it is not a
catalytic residue in the usual sense, but rather is a crucial element
in the functional linkage that coordinates the reactions occurring on
the GLN and CPS domains.
 |
EXPERIMENTAL PROCEDURES |
Materials--
[14C]Glutamine was purchased from
DuPont, HPLC-grade methanol was from Burdick and Jackson, and the
o-phthaldialdehyde (OPA) reagent solution and all other
chemicals were purchased from Sigma.
Plasmids and Strains--
The 7.1-kilobase plasmid pHGGLN52 (39)
carries a 1.1-kilobase insert encoding the mammalian CAD GLN domain in
a vector derived from pEK81 (40). The expression of the protein is
under control of the pyrBI promoter. The E. coli
host strain, EK1104 (40), lacks the pyrB and pyrI
genes and has a leaky pyrF mutation. The high copy number
plasmid PHN12 (41), which carries the carB gene that encodes
the large subunit of E. coli CPSase, was kindly provided by
Dr. Carol Lusty (The Public Health Research Institute of the City of
New York, New York, NY) as was the E. coli strain L673,
which is defective in the carA and carB genes,
encoding both E. coli carbamoyl-phosphate synthetase
subunits, as well as the Lon protease.
Cell Growth and Recombinant DNA Methods--
Cells harboring the
recombinant plasmids were routinely grown from a single colony in 2×
YT medium supplemented with 50-100 mg/liter ampicillin. The expression
of the mammalian GLN domain in EK1104 transformants was induced as
described previously (39), while the E. coli CPS subunit is
expressed constitutively (42) in L673 cells transformed with pHN12, a
plasmid encoding the E. coli CPSase large subunit. Plasmids
were isolated using the Bio101 RPM kit. Transformation and preparation
of competent E. coli cells were carried out by the Hanahan
procedure (43). Site-directed mutagenesis was carried out by PCR using
the Stratagene QuickChangeTM site-directed mutagenesis kit
and PfuTurboTM DNA polymerase, which replicates both
plasmid strands with high fidelity. Oligonucleotide primers were
obtained from Life Technologies, Inc. Custom Primers. Following PCR,
the product was treated with DpnI endonuclease to digest the
parental DNA template. The nicked vector DpnI-treated DNA
was then transformed in E. coli Epicurian Coli XL1-Blue
supercompetent cells. Colonies were grown and the DNA isolated and
sequenced by the double-stranded dideoxy method at the Wayne State
University Core Facility. The mutant plasmid was then transformed into
the EK1104 strain. Restriction digests, ligations, and other DNA
methods were carried out using standard protocols (44).
Protein Methods--
CAD was isolated from an overproducing
strain of Syrian hamster cells (BHK-128) as described previously (5,
45). The E. coli CPSase large subunit was isolated from
pHN12 transformants using the methods of Rubino et al. (42).
The wild type CAD GLN domain and the mutant were isolated by the method
described earlier (39). To form the hybrid CPSase (GLN-CPS),
stoichiometric amounts of the wild type CAD GLN domain or its mutant
and the E. coli CPSase large subunit were mixed together and
incubated for 15 min (31, 39). The complex was then concentrated using
either a Speed-Vac at room temperature or by centrifugation using
Millipore Ultrafree-MC 30,000 NMWL filter units at 4 °C. Protein
concentrations were determined by the Bradford dye binding method using
bovine serum albumin as a standard (46). SDS-gel electrophoresis was carried out on 10% polyacrylamide gels (47).
Molecular Modeling--
The structure of the CAD GLN-CPS domains
was modeled with E. coli CPSase (Brookhaven Protein Data
Bank; identification code 1JDB) serving as the tertiary template using
the program Quanta version 4.0 (MSI). The alignment of CAD and E. coli CPSase sequences was carried out giving equal weight to
secondary structure and sequence similarity. Undefined regions were
regularized in two stages, 50 cycles of steepest descent, followed by
200 cycles of adopted basis set NR, prior to final energy minimization.
Enzyme Assays--
The CPSase activity was assayed at 37 °C
using a radiometric procedure described previously (6, 48) using a 2 mm excess of MgCl2 over the concentration of
ATP in the assay. The GLNase activity (31) of the isolated CAD GLN
domain and the mammalian-E. coli CPSase hybrid complex was
measured by an assay that involved separating the reactant glutamine
from the product glutamate by HPLC as described below. The assay buffer
contained 25 mM HEPES, pH 7.4, 0.5 mM
dithiothreitol, 0.05 mM EDTA, 25 mM KCl (with
or without 10 mM ATP, 12 mM MgCl2,
15 mM NaHCO3), and variable glutamine in a
total volume of 0.35 ml. The reaction was initiated by adding 7-17
µg of the GLN domain in 50 µl, allowed to proceed for 1 h at
37 °C, and then quenched with 100 µl of 20% trichloroacetic acid.
The samples stood on ice for 10 min prior to centrifugation for 5 min
at 14,000 rpm to remove the precipitated protein. The supernatant (60 µl) was then neutralized with 10.8 µl of 1.2 M NaOH.
For glutamine concentrations less than 10 mM, the samples were derivatized by directly adding 100 µl of OPA reagent to the neutralized sample. At higher glutamine concentrations, 200 µl of OPA
reagent was added to 10 µl of the neutralized protein solution. Exactly 90 s following the addition of OPA, a 100-µl sample was injected onto the HPLC column. The activity is expressed as
nanomoles/min/mg of the GLN domain, and the amounts assayed given in
the legends represent micrograms of the GLN domain.
Gel Filtration--
The formation of a complex between the
isolated 38-kDa mammalian GLN domain and the mutant, with the 120-kDa
E. coli CPSase synthetase subunit, was verified by gel
filtration. The hybrid (45-50 µg) in 0.1 M potassium
phosphate, pH 7.6, 1 mM EDTA and 5% glycerol was applied
to a 1.5 × 63-cm Sephacryl S-300 column. The column was
pre-equilibrated and eluted at 0.2 ml/min with the same buffer. Column
fractions were analyzed by assaying CPSase and by SDS-gel electrophoresis.
 |
RESULTS |
Mutation of Serine 44--
The mammalian GLN domain was modeled
using the E. coli CPSase structure (23) as a template. As
expected, given the strong sequence similarity of the mammalian and
bacterial proteins, the configuration of active site residues closely
resembles that observed for the E. coli enzyme.
Ser44 (corresponding to Ser47 in the E. coli structure) is located within the catalytic site of the GLN
domain. The side chain extends into the site (Fig. 1) with its
-oxygen atom positioned
within 4.2 Å of the Cys252 sulfur atom and 4.9 Å from the
ring nitrogen of the catalytic histidine residue,
His336.

View larger version (76K):
[in this window]
[in a new window]
|
Fig. 1.
Model of the active site region of CPSase GLN
domain. The GLN subunit consists of two subdomains, the catalytic
(dark shading) and the attenuation subdomain
(light shading). The diagram shows the location
of the active site residues Cys252 and His336,
but Glu338 located in close proximity to His336
is partially obscured in this orientation and was omitted for clarity.
Ser44, which is located within the attenuation subdomain,
extends into the active site region of the catalytic subunit. A part of
the interface between the GLN domain and part of the CPS domain (shown
in black) is also visible. The structure was modeled based
on the E. coli CPSase x-ray structure (23).
|
|
Ser44 was replaced with alanine by PCR-directed mutagenesis
using the plasmid pHGGLN52 (39) as a template. High levels of the
38-kDa wild type and mutant domains were expressed when the plasmids
were transformed into the E. coli strain EK1104. Both proteins were purified to homogeneity as described (39) previously. Gel
filtration on a Sephacryl S-300 column showed that, as in the case of
the wild type protein, a stoichiometric mixture of the mammalian
Ser44
Ala GLN domain and the E. coli CPSase
CPS subunit formed a stable hybrid complex.
The Ser44
Ala Mutation Activates the Isolated GLN
Domain--
The isolated GLN domain had very low catalytic activity
(Table I), a consequence of a high
Km (4 mM) and a very low
kcat (0.020 s
1). The formation of
a hybrid complex consisting of the mammalian GLN domain and the
isolated E. coli CPS subunit restored the function of the
GLN domain. The Km decreased 45-fold while the kcat increased 15-fold relative to the isolated
domain. The steady state kinetic parameters of the hybrid are similar
to those obtained for CAD.
Contrary to the results that would be expected if Ser44
were a catalytic residue, the suppression of catalytic activity of the isolated domain was largely relieved by its replacement with alanine (Fig. 2 and Table I). Compared with the
isolated wild type domain, the Km was reduced
7-fold, while the kcat increased 21-fold. Thus,
the mutation appreciably activated the isolated GLN domain, increasing
the kcat/Km by a factor of
680.

View larger version (19K):
[in this window]
[in a new window]
|
Fig. 2.
Glutaminase activity of the wild type and
Ser44 Ala GLN domain. The glutaminase activity of
16.5 µg of the isolated wild type ( ) GLN domain and 15 µg of the
Ser44 Ala mutant ( ) was assayed by the HPLC method
described under "Experimental Procedures." The wild type activity
is also shown using an expanded scale in the inset. The axis
labels of the inset are the same as those of the
figure.
|
|
The formation of the hybrid with the Ser44
Ala GLN
domain gave a species with kinetic parameters similar to those obtained for the wild type complex, although the kcat and
Vmax values are about 1.7-fold higher. Compared
with the isolated Ser44
Ala GLN domain, the
Km for glutamine was reduced another 6-fold in the
mutant hybrid, but there was no appreciable change in
kcat.
Thus, Ser44 does not participate in glutamine hydrolysis in
either the isolated domain or the hybrid in the absence of ATP and bicarbonate.
The Mutant Hybrid Protein Catalyzes the Synthesis of Carbamoyl
Phosphate--
The Ser44
Ala hybrid protein can also
catalyze the overall synthesis of carbamoyl phosphate. Saturation
curves for the overall reaction (Fig. 3,
A and B, and Table
II) show that the Km for both glutamine and ATP are very similar to the values
determined for the wild type hybrid. However, the
kcat values obtained from both glutamine (0.193 s
1) and ATP (0.164 s
1) are approximately
14-fold lower for the mutant protein.

View larger version (16K):
[in this window]
[in a new window]
|
Fig. 3.
Carbamoyl phosphate synthesis by the wild
type and mutant hybrids. The carbamoyl-phosphate synthetase
activity of the wild type ( ) and mutant hybrids ( ) was assayed by
the radiometric method described under "Experimental Procedures."
Panel A, CPSase activity of 7 µg of the wild
type and 12 µg of the mutant hybrid measured versus
glutamine concentration. Panel B, CPSase activity
of 9.8 µg of the wild type and 12 µg of the mutant hybrid measured
versus ATP concentration. Panel C, a
replot of the data for the rate of glutamine hydrolysis in the presence
of ATP and bicarbonate (see Fig. 4) against the rate of carbamoyl
phosphate synthesis (A) measured at variable glutamine
concentration. The slope for the wild type ( ) and mutant ( )
proteins represents the amount of glutamine hydrolyzed for each mole of
carbamoyl phosphate synthesized.
|
|
ATP and Bicarbonate Do Not Activate the Glutaminase Reaction in the
Mutant--
The binding of ATP and bicarbonate to the CPS subunit
stimulates the GLNase activity of the wild type hybrid and CAD 10- and 14-fold, respectively. The stimulation is the result of a corresponding increase in kcat, without any significant change
in the affinity for glutamine. In the absence of ATP and bicarbonate
(Fig. 4, Table I), the
kcat for glutamine hydrolysis of the mutant
hybrid (0.525 s
1) is only marginally increased compared
with that of the wild type hybrid (0.309 s
1) and it does
not significantly change in the presence of saturating concentrations
of these substrates (0.552 s
1). Thus, the functional
linkage that coordinates the reactions on the GLN and CPS domains is
lost as a result of replacement of Ser44 with alanine.

View larger version (18K):
[in this window]
[in a new window]
|
Fig. 4.
Glutaminase of the GLN-CPS hybrid in the
presence and absence of saturating ATP and bicarbonate. A hybrid
complex of the mammalian GLN domain and the E. coli CPS
subunit was formed as described under "Experimental Procedures."
The hybrid with the wild type GLN domain (7 µg of the GLN domain) was
assayed in the presence of 10 mM ATP and 15 mM
bicarbonate ( ) and in the absence of these substrates ( ).
Similarly, the Ser44 Ala hybrid complex (12 µg of the
GLN domain) was also assayed in the presence ( ) and absence of ATP
and bicarbonate ( ). The solid lines represent
a least squares fit to the Michaelis-Menten equation.
|
|
Coordination between the Activation of Bicarbonate and Glutamine
Hydrolysis Is Lost in the Mutant--
In CAD and in the wild type
hybrid complex, the rate of glutamine hydrolysis is closely matched to
the rate of carbamoyl phosphate synthesis. The maximum velocity for
glutamine hydrolysis in the presence of saturating ATP and bicarbonate
(Table I, kcat = 3.11 s
1)
parallels the overall rate of carbamoyl phosphate synthesis (Table II,
kcat = 2.66 s
1) in the wild type
hybrid. Moreover, a replot (Fig. 3C) of the velocity data of
carbamoyl phosphate synthesized (Fig. 3A) versus glutamine hydrolyzed (Fig. 4) measured at various concentrations of
glutamine gives a slope of 1.15 ± 0.04, in accord with the expected stoichiometry of the overall reaction at all concentrations of
the substrate.
In contrast, the rate of glutamine hydrolysis exceeds the rate of
carbamoyl phosphate synthesized in the mutant hybrid. The kcat for the GLNase reaction measured at
saturating ATP and bicarbonate is 0.552 s
1, whereas the
kcat for the CPSase reaction is only 0.193 s
1. Similarly, the plot of glutamine hydrolysis
versus carbamoyl phosphate synthesized had a slope of
2.9 ± 0.1, indicating that the 1:1 stoichiometry observed for the
reaction catalyzed by the wild type enzyme is not sustained in the
mutant. This result would be expected if Ser44 plays a
major role in phasing the reactions occurring on the two domains.
 |
DISCUSSION |
Carbamoyl phosphate synthesis involves the concerted action of two
domains that must act in synchrony. We are especially interested in the
mechanism of glutamine hydrolysis and the reciprocal interactions between the GLN and CPS domains of the mammalian multifunctional protein CAD. Although we have expressed each of the functional domains,
we cannot as yet obtain sufficient amounts of CPS needed for the sorts
of studies described here. However, previous steady state and presteady
state kinetic studies (31, 39) showed that the hybrid consisting of the
isolated mammalian GLN domain and the E. coli CPS subunit
has catalytic parameters similar to CAD as well as a functional
interdomain linkage. Thus, we have used this system to assess the role
of Ser44 in carbamoyl phosphate synthesis.
Whereas the hydrolysis of glutamine by CAD can be easily measured, the
isolated GLN domain has barely detectable activity as a result of an
appreciable increase in the Km for glutamine and
decrease in kcat. However, the kinetic
parameters are restored to the normal values found in CAD when a
stoichiometric complex is formed by the non-covalent association of the
isolated GLN domain and the CPS subunit of E. coli CPSase.
Sequence comparisons (10, 11) showed that the 40-kDa CPSase GLN domain
consists of two distinct regions. The carboxyl half of the domain is
homologous to the amidotransferase domain of all trpG or triad type
amidotransferases (33, 34, 49), while the amino half of the domain is
unique to the CPSases. Since amidotransferase domains of the other
biosynthetic enzymes have an average molecular mass of 20 kDa and do
not have a chain segment corresponding to the amino half of the CPS GLN domain, it was reasonable to assume that all of the residues required for glutamine binding and catalysis would be found in the carboxyl half
of the CAD GLN domain. Support for this interpretation was obtained
when we cloned and expressed (50) the two halves of the mammalian
CPSase GLN domain and showed that they are autonomously folded
subdomains with specific functions. The amino half has no catalytic
activity but forms a stable complex with the CPS domain. The carboxyl
half, the catalytic subdomain, binds glutamine with the same affinity
and is more active (kcat = 5.7 s
1)
than the maximum glutaminase activity observed for intact CAD, even
when assayed in the presence of saturating ATP and
HCO3
(kcat = 1.9 s
1). We therefore suggested that a major function of
the amino half of the GLN domain, the attenuation subdomain, was to
modulate the intrinsically high catalytic activity of the catalytic
subdomain and that this region of the molecule was instrumental in
relaying the interdomain signal between the GLN and CPS domains. In
accord with this hypothesis, the x-ray structure of E. coli
CPSase (23) subsequently showed that the attenuation subdomain makes
extensive contacts with the CPS subunit in E. coli CPSase.
The x-ray structure also showed that Ser44 is the only
residue in the attenuation subdomain that extends into the GLN active
site, making it a prime candidate for participation in the functional linkage.
The activation of the GLN domain that occurs upon association with the
CPSase subunit is almost entirely mimicked by the replacement of
Ser44 with alanine in the isolated domain. The
kcat increases 20-fold to 0.43 s
1
compared with a value of 0.31 s
1 for the wild type hybrid
complex. The high activity of the isolated Ser44
Ala
GLN domain confirms that this serine residue is not involved in
catalysis. The Km also decreases to 0.6 mM in the isolated Ser44
Ala domain, but is
still 6-fold higher than that of the wild type hybrid complex. One
could argue that this residue is important for binding glutamine, but,
when the Ser44
Ala GLN domain associates with the
E. coli CPS subunit, the Km is virtually
the same as the wild type hybrid complex. Thus, it seems clear that the
suppression of activity in the isolated GLN domain is, to a large
extent, the result of the serine residue. Since alanine is nearly
isosteric with serine, the depression of activity is unlikely to be a
consequence of steric interference, suggesting that Ser44
may form a hydrogen bond with one of the active site residues that
interferes with its normal function in catalysis.
When the wild type isolated domain combines with the CPS subunit,
Ser44 is likely to be displaced to its position located in
the electron density maps of E. coli CPSase (23). Since the
serine residue has been replaced in the mutant, little change would
be expected when the Ser44
Ala domain combines with the
CPS subunit. Consistent with this interpretation, the kinetic
parameters for glutamine hydrolysis by the Ser44
Ala
hybrid are similar to the values measured for the wild type hybrid
complex, suggesting that Ser44 is not required for
glutamine hydrolysis by the hybrid in the absence of ATP and
HCO3
.
The hydrolysis of glutamine and the activation of bicarbonate are
parallel reactions that must occur in phase to avoid the wasteful
hydrolysis of glutamine or ATP that would otherwise occur. This
requirement is especially important since the active sites are far from
one another, about 45 Å in the E. coli structure (23), and
ammonia must be delivered to the active site of CPS.A via a long
interdomain tunnel. The coordination of these partial reactions
requires that the GLNase activity be modulated so that it is not
operating at or near its full catalytic potential unless the
concentration of the other substrates needed for carbamoyl phosphate
synthesis are saturating. A part of the interdomain functional linkage
is the down-regulation of the glutaminase activity when ATP and
bicarbonate are limiting. Steady state and presteady state kinetic
studies of CAD (28, 31) showed that, in the absence of ATP and
bicarbonate, the thioester intermediate accumulates and the rate
constant for the breakdown of the thioester intermediate is the same as
the kcat for glutamine hydrolysis, indicating
that it is the rate-limiting step. When ATP and bicarbonate are
present, the breakdown of the thioester is accelerated, the
intermediate cannot be detected, and the kcat
for the hydrolysis of glutamine increases 14-fold. Since the substrate
induced acceleration of catalysis is due to an increase in
kcat without an apparent change on glutamine
binding, it is likely that the juxtaposition of catalytic residues is
suboptimal in the absence of ATP and bicarbonate. Similar results have
been reported (29, 30) for E. coli CPSase. The functional
linkage is abolished in the Ser44
Ala hybrid. The
addition of ATP and bicarbonate has no significant effect on either the
Km or the kcat of the hybrid,
suggesting that Ser44 is essential for transmission of the
allosteric signal that up-regulates the GLN domain. Since activation
primarily involves an increase in the rate of breakdown of the
thioester, it is possible that Ser44 promotes its
hydrolysis, but only when ATP and bicarbonate are bound to the CPS domain.
If this functional linkage is important in phasing the reactions
occurring on the GLN and CPS domains, then the rate of glutamine hydrolysis need no longer match the rate of carbamoyl phosphate synthesis if the linkage is disrupted. The stoichiometry of carbamoyl phosphate synthesis is tightly controlled in the wild type hybrid, with
1 mol of glutamine hydrolyzed/mol of carbamoyl phosphate synthesized.
In contrast, the mutant hybrid hydrolyzed 3 times more glutamine than
that needed for carbamoyl phosphate synthesis, with the excess
presumably leaking out of the complex.
We conclude that serine 44 in the GLN attenuation domain is not a
catalytic residue in the usual sense but rather is an essential component in the regulatory linkage that phases glutamine hydrolysis and carbamoyl phosphate synthesis.
 |
ACKNOWLEDGEMENT |
We thank Dr. Carol Lusty for the generous
gifts of plasmids and strains.
 |
FOOTNOTES |
*
This work was supported by United States Public Health
Service Grant GM47399.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed. Tel.: 313-577-1016;
Fax: 313-577-1510; E-mail: devans@cmb.biosci.wayne.edu.
 |
ABBREVIATIONS |
The abbreviations used are:
CPSase, carbamoyl-phosphate synthetase activity;
CAD, the multifunctional
protein having glutamine-dependent carbamoyl-phosphate
synthetase, aspartate transcarbamoylase, and dihydroorotase activities;
CPS, the synthetase domain or subunit of
carbamoyl-phosphate synthetase;
GLN, the amidotransferase or
glutaminase domain or subunit of carbamoyl-phosphate synthetase;
GLNase, glutaminase activity;
GLN-CPS, the hybrid CPSase consisting of
the mammalian GLN domain and the E. coli CPS domain;
PCR, polymerase chain reaction;
HPLC, high performance liquid
chromatography;
OPA, o-phthaldialdehyde.
 |
REFERENCES |
| 1.
|
Anderson, P. M.,
and Meister, A.
(1966)
Biochemistry
5,
3157-3163[CrossRef][Medline]
[Order article via Infotrieve]
|
| 2.
|
Meister, A.
(1989)
Adv. Enzymol. Relat. Areas Mol. Biol.
62,
315-374[Medline]
[Order article via Infotrieve]
|
| 3.
|
Shoaf, W. T.,
and Jones, M. E.
(1973)
Biochemistry
12,
4039-4051[CrossRef][Medline]
[Order article via Infotrieve]
|
| 4.
|
Mori, M.,
Ishida, H.,
and Tatibana, M.
(1975)
Biochemistry
14,
2622-2630[CrossRef][Medline]
[Order article via Infotrieve]
|
| 5.
|
Coleman, P.,
Suttle, D.,
and Stark, G.
(1977)
J. Biol. Chem.
252,
6379-6385[Abstract/Free Full Text]
|
| 6.
|
Mally, M. I.,
Grayson, D. R.,
and Evans, D. R.
(1981)
Proc. Natl. Acad. Sci. U. S. A.
78,
6647-6651[Abstract/Free Full Text]
|
| 7.
|
Davidson, J. N.,
Rumsby, P. C.,
and Tamaren, J.
(1981)
J. Biol. Chem.
256,
5220-5225[Abstract/Free Full Text]
|
| 8.
|
Grayson, D. R.,
Lee, L.,
and Evans, D. R.
(1985)
J. Biol. Chem.
260,
15840-15849[Abstract/Free Full Text]
|
| 9.
|
Kim, H.,
Kelly, R. E.,
and Evans, D. R.
(1992)
J. Biol. Chem.
267,
7177-7184[Abstract/Free Full Text]
|
| 10.
|
Simmer, J. P.,
Kelly, R. E.,
Rinker, A. G., Jr.,
Scully, J. L.,
and Evans, D. R.
(1990)
J. Biol. Chem.
265,
10395-10402[Abstract/Free Full Text]
|
| 11.
|
Bein, K.,
Simmer, J.,
and Evans, D.
(1991)
J. Biol. Chem.
266,
3791-3799[Abstract/Free Full Text]
|
| 12.
|
Nyunoya, H.,
and Lusty, C. J.
(1983)
Proc. Natl. Acad. Sci. U. S. A.
80,
4629-4633[Abstract/Free Full Text]
|
| 13.
|
Anderson, P. M.
(1995)
in
Nitrogen Metabolism and Excretion
(Walsh, P. J.
, and Wright, P. A., eds)
, pp. 33-55, CRC Press, Boca Raton, FL
|
| 14.
|
Trotta, P. P.,
Burt, M. E.,
Haschemeyer, R. H.,
and Meister, A.
(1971)
Proc. Natl. Acad. Sci. U. S. A.
68,
2599-2603[Abstract/Free Full Text]
|
| 15.
|
Trotta, P. P.,
Estis, L. F.,
Meister, A.,
and Haschemeyer, R. H.
(1974)
J. Biol. Chem.
249,
482-489[Abstract/Free Full Text]
|
| 16.
|
Powers-Lee, S. G.,
Mastico, R. A.,
and Bendayan, M.
(1987)
J. Biol. Chem.
262,
15683-15688[Abstract/Free Full Text]
|
| 17.
|
Boettcher, B. R.,
and Meister, A.
(1980)
J. Biol. Chem.
255,
7129-7133[Free Full Text]
|
| 18.
|
Kim, H. S.,
Lee, L.,
and Evans, D. R.
(1991)
Biochemistry
30,
10322-10329[CrossRef][Medline]
[Order article via Infotrieve]
|
| 19.
|
Potter, M. D.,
and Powers-Lee, S. G.
(1992)
J. Biol. Chem.
267,
2023-2031[Abstract/Free Full Text]
|
| 20.
|
Post, L. E.,
Post, D. J.,
and Raushel, F. M.
(1990)
J. Biol. Chem.
265,
7742-7747[Abstract/Free Full Text]
|
| 21.
|
Javid-Majd, F.,
Stapleton, M. A.,
Harmon, M. F.,
Hanks, B. A.,
Mullins, L. S.,
and Raushel, F. M.
(1996)
Biochemistry
35,
14362-14369[CrossRef][Medline]
[Order article via Infotrieve]
|
| 22.
|
Stapleton, M. A.,
Javid-Majd, F.,
Harmon, M. F.,
Hanks, B. A.,
Grahmann, J. L.,
Mullins, L. S.,
and Raushel, F. M.
(1996)
Biochemistry
35,
14352-14361[CrossRef][Medline]
[Order article via Infotrieve]
|
| 23.
|
Thoden, J. B.,
Holden, H. M.,
Wesenberg, G.,
Raushel, F. M.,
and Rayment, I.
(1997)
Biochemistry
36,
6305-6316[CrossRef][Medline]
[Order article via Infotrieve]
|
| 24.
|
Thoden, J. B.,
Miran, S. G.,
Phillips, J. C.,
Howard, A. J.,
Raushel, F. M.,
and Holden, H. M.
(1998)
Biochemistry
37,
8825-8831[CrossRef][Medline]
[Order article via Infotrieve]
|
| 25.
|
Thoden, J. B.,
Wesenberg, G.,
Raushel, F. M.,
and Holden, H. M.
(1999)
Biochemistry
38,
2347-2357[CrossRef][Medline]
[Order article via Infotrieve]
|
| 26.
|
Thoden, J. B.,
Raushel, F. M.,
Benning, M. M.,
Rayment, I.,
and Holden, H. M.
(1999)
Acta Crystallogr. D Biol. Crystallogr.
55,
8-24[CrossRef][Medline]
[Order article via Infotrieve]
|
| 27.
|
Wellner, V. P.,
Anderson, P. M.,
and Meister, A.
(1973)
Biochemistry
12,
2061-2066[CrossRef][Medline]
[Order article via Infotrieve]
|
| 28.
|
Chaparian, M. G.,
and Evans, D. R.
(1991)
J. Biol. Chem.
266,
3387-3395[Abstract/Free Full Text]
|
| 29.
|
Lusty, C. J.,
and Liao, M.
(1993)
Biochemistry
32,
1278-1284[CrossRef][Medline]
[Order article via Infotrieve]
|
| 30.
|
Miles, B. W.,
Banzon, J. A.,
and Raushel, F. M.
(1998)
Biochemistry
37,
16773-16779[CrossRef][Medline]
[Order article via Infotrieve]
|
| 31.
|
Hewagama, A.,
Guy, H. I.,
Chaparian, M.,
and Evans, D. R.
(1998)
Biochim. Biophys. Acta
1388,
489-499[CrossRef][Medline]
[Order article via Infotrieve]
|
| 32.
|
Mei, B.,
and Zalkin, H.
(1989)
J. Biol. Chem.
264,
16613-16619[Abstract/Free Full Text]
|
| 33.
|
Zalkin, H., and Smith, J. L.
(eds)
(1998)
in
Enzymes Utilizing Glutamine as an Amide Donor: in Amino Acid Metabolism, Part A
(Purich, D. L., ed), Vol. 72
, pp. 87-144, John Wiley and Sons, Inc., New York
|
| 34.
|
Massiere, F.,
and Badet-Denisot, M.-A.
(1998)
Cell. Mol. Life Sci.
54,
205-222[CrossRef][Medline]
[Order article via Infotrieve]
|
| 35.
|
Khedouri, E.,
Anderson, P. M.,
and Meister, A.
(1966)
Biochemistry
5,
3552-3557[CrossRef][Medline]
[Order article via Infotrieve]
|
| 36.
|
Anderson, P. M.,
Carlson, J. D.,
Rosenthal, G. A.,
and Meister, A.
(1973)
Biochem. Biophys. Res. Commun.
55,
246-252[Medline]
[Order article via Infotrieve]
|
| 37.
|
Trotta, P. P.,
Pinkus, L. M.,
Haschemeyer, R. H.,
and Meister, A.
(1974)
J. Biol. Chem.
249,
492-499[Abstract/Free Full Text]
|
| 38.
|
Anderson, P. M.,
and Carlson, J. D.
(1975)
Biochemistry
14,
3688-3694[CrossRef][Medline]
[Order article via Infotrieve]
|
| 39.
|
Guy, H. I.,
and Evans, D. R.
(1994)
J. Biol. Chem.
269,
7702-7708[Abstract/Free Full Text]
|
| 40.
|
Nowlan, S. F.,
and Kantrowitz, E. R.
(1985)
J. Biol. Chem.
260,
14712-14716[Abstract/Free Full Text]
|
| 41.
|
Guillou, F.,
Rubino, S. D.,
Markovitz, R. S.,
Kinney, D. M.,
and Lusty, C. J.
(1989)
Proc. Natl. Acad. Sci. U. S. A.
86,
8304-8308[Abstract/Free Full Text]
|
| 42.
|
Rubino, S. D.,
Nyunoya, H.,
and Lusty, C. J.
(1987)
J. Biol. Chem.
262,
4382-4386[Abstract/Free Full Text]
|
| 43.
|
Hanahan, D.
(1985)
in
DNA Cloning: A Practical Approach
(Glover, D. M., ed), Vol. 1
, IRL Press, New York
|
| 44.
|
Maniatis, T.,
Fritsch, E. R.,
and Sambrook, I.
(1982)
Molecular Cloning: A Laboratory Manual
, 1st Ed.
, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
|
| 45.
|
Mally, M. I.,
Grayson, D. R.,
and Evans, D. R.
(1980)
J. Biol. Chem.
255,
11372-11380[Free Full Text]
|
| 46.
|
Bradford, M. M.
(1976)
Anal. Biochem.
72,
248-254[CrossRef][Medline]
[Order article via Infotrieve]
|
| 47.
|
Laemmli, U. K.
(1970)
Nature
227,
680-685[CrossRef][Medline]
[Order article via Infotrieve]
|
| 48.
|
Christopherson, R. I.,
and Jones, M. E.
(1980)
J. Biol. Chem.
255,
11381-11395[Abstract/Free Full Text]
|
| 49.
|
Zalkin, H.
(1985)
Methods Enzymol.
113,
263-264[Medline]
[Order article via Infotrieve]
|
| 50.
|
Guy, H. I.,
and Evans, D. R.
(1995)
J. Biol. Chem.
270,
2190-2197[Abstract/Free Full Text]
|
Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
V. R. Young and A. M. Ajami
Glutamine: The Emperor or His Clothes?
J. Nutr.,
September 1, 2001;
131(9):
2449S - 2459.
[Abstract]
[Full Text]
[PDF]
|
 |
|